P702 F-calprotectin use in inflammatory bowel disease is characterized by improved diagnostic accuracy, less patient harm and decreased costs, compared with conventional serological markers and colonoscopy. A cost-effectiveness study in Italy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.